smscall
logo
Pharma & Healthcare

Published On: Jul 22, 2025

Global Granisetron Market Analysis and Forecast 2025-2031

  • starstarstarstarstar
  • 0
  • 0 Reviews
  • 203 Pages
  • 0 Views

Version Type

$4,950.00

Summary
According to APO Research, The global Granisetron market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Granisetron include Kyowa Kirin, Teva, Sandoz, Mylan, Fresenius Kabi, Wockhardt, Taro Pharmaceutical, Natco Pharma and Hikma Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Granisetron, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Granisetron, also provides the revenue of main regions and countries. Of the upcoming market potential for Granisetron, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Granisetron revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Granisetron market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Granisetron revenue, projected growth trends, production technology, application and end-user industry.
Granisetron Segment by Company
Kyowa Kirin
Teva
Sandoz
Mylan
Fresenius Kabi
Wockhardt
Taro Pharmaceutical
Natco Pharma
Hikma Pharmaceuticals
Heron Therapeutics
Dr.Reddy's
Cipla
Bluepharma
Aurobindo
APOTEX
Akorn
Granisetron Segment by Type
Injection
Transdermal system
Oral
Granisetron Segment by Application
Chemotherapy
Post operative
Granisetron Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Granisetron and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Granisetron in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Granisetron company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granisetron revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Table 1:Global Granisetron Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031
Table 2:Injection Major Player
Table 3:Transdermal system Major Player
Table 4:Oral Major Player
Table 5:Global Granisetron Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031
Table 6:Chemotherapy Major Player
Table 7:Post operative Major Player
Table 8:Granisetron Industry Trends
Table 9:Granisetron Industry Drivers
Table 10:Granisetron Industry Opportunities and Challenges
Table 11:Granisetron Industry Restraints
Table 12:Global Granisetron Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 13:Global Granisetron Market Size by Region (2020-2025) & (US$ Million)
Table 14:Global Granisetron Market Share by Region (2020-2025)
Table 15:Global Granisetron Market Size by Region (2026-2031) & (US$ Million)
Table 16:Global Granisetron Market Share by Region (2026-2031)
Table 17:Global Granisetron Revenue by Players (US$ Million) & (2020-2025)
Table 18:Global Granisetron Revenue Market Share by Players (2020-2025)
Table 19:Global Granisetron Key Players Ranking, 2023 VS 2024 VS 2025
Table 20:Global Granisetron Key Players Headquarters & Area Served
Table 21:Global Granisetron Players, Product Type & Application
Table 22:Global Granisetron Players Establishment Date
Table 23:Global Players Market Concentration Ratio (CR5 and HHI)
Table 24:Global Granisetron by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 25:Global Granisetron Revenue by Type 2020 VS 2024 VS 2031 (US$ Million)
Table 26:Global Granisetron Revenue by Type (2020-2025) & (US$ Million)
Table 27:Global Granisetron Revenue by Type (2026-2031) & (US$ Million)
Table 28:Global Granisetron Revenue Market Share by Type (2020-2025) & (US$ Million)
Table 29:Global Granisetron Revenue Market Share by Type (2026-2031) & (US$ Million)
Table 30:Global Granisetron Revenue by Application 2020 VS 2024 VS 2031 (US$ Million)
Table 31:Global Granisetron Revenue by Application (2020-2025) & (US$ Million)
Table 32:Global Granisetron Revenue by Application (2026-2031) & (US$ Million)
Table 33:Global Granisetron Revenue Market Share by Application (2020-2025) & (US$ Million)
Table 34:Global Granisetron Revenue Market Share by Application (2026-2031) & (US$ Million)
Table 35:Kyowa Kirin Company Information
Table 36:Kyowa Kirin Business Overview
Table 37:Kyowa Kirin Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 38:Kyowa Kirin Granisetron Product Portfolio
Table 39:Kyowa Kirin Recent Development
Table 40:Teva Company Information
Table 41:Teva Business Overview
Table 42:Teva Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 43:Teva Granisetron Product Portfolio
Table 44:Teva Recent Development
Table 45:Sandoz Company Information
Table 46:Sandoz Business Overview
Table 47:Sandoz Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 48:Sandoz Granisetron Product Portfolio
Table 49:Sandoz Recent Development
Table 50:Mylan Company Information
Table 51:Mylan Business Overview
Table 52:Mylan Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 53:Mylan Granisetron Product Portfolio
Table 54:Mylan Recent Development
Table 55:Fresenius Kabi Company Information
Table 56:Fresenius Kabi Business Overview
Table 57:Fresenius Kabi Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 58:Fresenius Kabi Granisetron Product Portfolio
Table 59:Fresenius Kabi Recent Development
Table 60:Wockhardt Company Information
Table 61:Wockhardt Business Overview
Table 62:Wockhardt Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 63:Wockhardt Granisetron Product Portfolio
Table 64:Wockhardt Recent Development
Table 65:Taro Pharmaceutical Company Information
Table 66:Taro Pharmaceutical Business Overview
Table 67:Taro Pharmaceutical Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 68:Taro Pharmaceutical Granisetron Product Portfolio
Table 69:Taro Pharmaceutical Recent Development
Table 70:Natco Pharma Company Information
Table 71:Natco Pharma Business Overview
Table 72:Natco Pharma Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 73:Natco Pharma Granisetron Product Portfolio
Table 74:Natco Pharma Recent Development
Table 75:Hikma Pharmaceuticals Company Information
Table 76:Hikma Pharmaceuticals Business Overview
Table 77:Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 78:Hikma Pharmaceuticals Granisetron Product Portfolio
Table 79:Hikma Pharmaceuticals Recent Development
Table 80:Heron Therapeutics Company Information
Table 81:Heron Therapeutics Business Overview
Table 82:Heron Therapeutics Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025)
Table 83:Heron Therapeutics Granisetron Product Portfolio
Table 84:Heron Therapeutics Recent Development
Table 85:Dr.Reddy's Company Information
Table 86:Dr.Reddy's Business Overview
Table 87:Dr.Reddy's Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
Table 88:Dr.Reddy's Granisetron Product Portfolio
Table 89:Dr.Reddy's Recent Development
Table 90:Cipla Company Information
Table 91:Cipla Business Overview
Table 92:Cipla Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
Table 93:Cipla Granisetron Product Portfolio
Table 94:Cipla Recent Development
Table 95:Bluepharma Company Information
Table 96:Bluepharma Business Overview
Table 97:Bluepharma Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
Table 98:Bluepharma Granisetron Product Portfolio
Table 99:Bluepharma Recent Development
Table 100:Aurobindo Company Information
Table 101:Aurobindo Business Overview
Table 102:Aurobindo Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
Table 103:Aurobindo Granisetron Product Portfolio
Table 104:Aurobindo Recent Development
Table 105:APOTEX Company Information
Table 106:APOTEX Business Overview
Table 107:APOTEX Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
Table 108:APOTEX Granisetron Product Portfolio
Table 109:APOTEX Recent Development
Table 110:Akorn Company Information
Table 111:Akorn Business Overview
Table 112:Akorn Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
Table 113:Akorn Granisetron Product Portfolio
Table 114:Akorn Recent Development
Table 115:North America Granisetron Revenue by Type (2020-2025) & (US$ Million)
Table 116:North America Granisetron Revenue by Application (2020-2025) & (US$ Million)
Table 117:North America Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 118:North America Granisetron Revenue by Country (2020-2025) & (US$ Million)
Table 119:North America Granisetron Revenue by Country (2026-2031) & (US$ Million)
Table 120:Europe Granisetron Revenue by Type (2020-2025) & (US$ Million)
Table 121:Europe Granisetron Revenue by Application (2020-2025) & (US$ Million)
Table 122:Europe Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 123:Europe Granisetron Revenue by Country (2020-2025) & (US$ Million)
Table 124:Europe Granisetron Revenue by Country (2026-2031) & (US$ Million)
Table 125:China Granisetron Revenue by Type (2020-2025) & (US$ Million)
Table 126:China Granisetron Revenue by Application (2020-2025) & (US$ Million)
Table 127:Asia Granisetron Revenue by Type (2020-2025) & (US$ Million)
Table 128:Asia Granisetron Revenue by Application (2020-2025) & (US$ Million)
Table 129:Asia Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 130:Asia Granisetron Revenue by Country (2020-2025) & (US$ Million)
Table 131:Asia Granisetron Revenue by Country (2026-2031) & (US$ Million)
Table 132:SAMEA Granisetron Revenue by Type (2020-2025) & (US$ Million)
Table 133:SAMEA Granisetron Revenue by Application (2020-2025) & (US$ Million)
Table 134:SAMEA Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 135:SAMEA Granisetron Revenue by Country (2020-2025) & (US$ Million)
Table 136:SAMEA Granisetron Revenue by Country (2026-2031) & (US$ Million)
Table 137:Research Programs/Design for This Report
Table 138:Authors List of This Report
Table 139:Secondary Sources
Table 140:Primary Sources
Figure 1:Granisetron Image
Figure 2:Global Granisetron Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031
Figure 3:Global Granisetron Market Size Share 2020 VS 2024 VS 2031
Figure 4:Injection Image
Figure 5:Transdermal system Image
Figure 6:Oral Image
Figure 7:Global Granisetron Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031
Figure 8:Global Granisetron Market Size Share 2020 VS 2024 VS 2031
Figure 9:Chemotherapy Image
Figure 10:Post operative Image
Figure 11:Global Granisetron Market Size (US$ Million) & (2020-2031)
Figure 12:Global Granisetron Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13:Global Granisetron Market Share by Region: 2020 VS 2024 VS 2031
Figure 14:Global Granisetron Players Revenue Share Top 10 and Top 5 in 2024
Figure 15:Players Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 16:Global Granisetron Revenue by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17:Global Granisetron Revenue Market Share 2020 VS 2024 VS 2031
Figure 18:Global Granisetron Revenue Market Share by Type (2020-2031)
Figure 19:Global Granisetron Revenue by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 20:Global Granisetron Revenue Market Share by Application (2020 VS 2024 VS 2031)
Figure 21:Global Granisetron Revenue Market Share by Application (2020-2031)
Figure 22:North America Granisetron Revenue YoY Growth (2020-2031) & (US$ Million)
Figure 23:North America Granisetron Revenue by Type (2026-2031) & (US$ Million)
Figure 24:North America Granisetron Revenue Share by Type (2020-2031)
Figure 25:North America Granisetron Revenue by Application (2026-2031) & (US$ Million)
Figure 26:North America Granisetron Revenue Share by Application (2020-2031)
Figure 27:North America Granisetron Revenue Share by Country (2020-2031)
Figure 28:United States Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 29:Canada Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 30:Mexico Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 31:Europe Granisetron Revenue YoY Growth (2020-2031) & (US$ Million)
Figure 32:Europe Granisetron Revenue by Type (2026-2031) & (US$ Million)
Figure 33:Europe Granisetron Revenue Share by Type (2020-2031)
Figure 34:Europe Granisetron Revenue by Application (2026-2031) & (US$ Million)
Figure 35:Europe Granisetron Revenue Share by Application (2020-2031)
Figure 36:Europe Granisetron Revenue Share by Country (2020-2031)
Figure 37:Germany Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 38:France Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 39:U.K. Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 40:Italy Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 41:Spain Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 42:Russia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 43:Netherlands Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 44:Nordic Countries Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 45:China Granisetron Revenue YoY Growth (2020-2031) & (US$ Million)
Figure 46:China Granisetron Revenue by Type (2026-2031) & (US$ Million)
Figure 47:China Granisetron Revenue Share by Type (2020-2031)
Figure 48:China Granisetron Revenue by Application (2026-2031) & (US$ Million)
Figure 49:China Granisetron Revenue Share by Application (2020-2031)
Figure 50:Asia Granisetron Revenue YoY Growth (2020-2031) & (US$ Million)
Figure 51:Asia Granisetron Revenue by Type (2026-2031) & (US$ Million)
Figure 52:Asia Granisetron Revenue Share by Type (2020-2031)
Figure 53:Asia Granisetron Revenue by Application (2026-2031) & (US$ Million)
Figure 54:Asia Granisetron Revenue Share by Application (2020-2031)
Figure 55:Asia Granisetron Revenue Share by Country (2020-2031)
Figure 56:Japan Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 57:South Korea Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 58:India Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 59:Australia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 60:Taiwan Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 61:Southeast Asia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 62:SAMEA Granisetron Revenue YoY Growth (2020-2031) & (US$ Million)
Figure 63:SAMEA Granisetron Revenue by Type (2026-2031) & (US$ Million)
Figure 64:SAMEA Granisetron Revenue Share by Type (2020-2031)
Figure 65:SAMEA Granisetron Revenue by Application (2026-2031) & (US$ Million)
Figure 66:SAMEA Granisetron Revenue Share by Application (2020-2031)
Figure 67:SAMEA Granisetron Revenue Share by Country (2020-2031)
Figure 68:Brazil Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 69:Argentina Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 70:Chile Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 71:Colombia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 72:Peru Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 73:Saudi Arabia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 74:Israel Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 75:UAE Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 76:Turkey Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 77:Iran Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 78:Egypt Granisetron Revenue YoY Growth (US$ Million) & (2020-2031)
Figure 79:Years Considered
Figure 80:Research Process
Figure 81:Key Executives Interviewed

Request a Sample

Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Report Cover

Pharma & Healthcare

Global Granisetron Market Analysis and Forecast 2025-2031

0| 0 Reviews

Pages: 203

Complete Your Request

Select Country
Phone

Customer reviews

  • starstarstarstarstar
  • 0 out of 5
  • 0 Reviews

5

star rating

4

star rating

3

star rating

2

star rating

1

star rating

No Rating Review Exist.

Write Review
  • starstarstarstarstar

Suggested Report

View More

No data found.